Product Information
MUPIROCIN 2% CREAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.8260 per GM under NDC 68462056417. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 24, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 g/100g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462056417
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
MUPIROCIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA201587FDA Approved
1/24/2013
TE Code
AB
On Market Since
1/24/2013
Pharmacological Classes
Price Statistics
The NADAC for MUPIROCIN 2% CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 69.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8260 per GM |
|---|---|
| All-time high | $11.5062 (Nov 11, 2020) |
| All-time low | $0.8040 (Jul 17, 2024) |
| 52-week high | $1.2603 |
| 52-week low | $0.8260 |
| Median price | $6.1065 |
| Average price | $5.8484 |
| Largest weekly change | +72.0% (Dec 23, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mupirocin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
RNA Synthetase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUPIROCIN 2% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for MUPIROCIN 2% CREAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.8260 per GM (NDC 68462056417), effective Sep 30, 2026.
How has the price of MUPIROCIN 2% CREAM changed over time?
Over the history we have for it, the NADAC for MUPIROCIN 2% CREAM has declined 69.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MUPIROCIN 2% CREAM?
Since Nov 28, 2013, the NADAC for MUPIROCIN 2% CREAM has ranged from a low of $0.8040 (Jul 17, 2024) to a high of $11.5062 (Nov 11, 2020), with a median of $6.1065 per GM.
Are there cheaper alternatives to MUPIROCIN 2% CREAM?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MUPIROCIN 2% CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures MUPIROCIN 2% CREAM?
MUPIROCIN 2% CREAM (NDC 68462056417) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.